12:00 AM
 | 
Aug 03, 2015
 |  BC Week In Review  |  Company News  |  Deals

Amarna Therapeutics, CBMed deal

Amarna and CBmed partnered to develop immunotherapies to treat acute lymphoblastic leukemia (ALL), obesity, Type II diabetes and atherosclerotic cardiovascular disease. Amarna will provide...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >